Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 457 record(s)

Req # A-2022-001456

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-113333-209.

Organization: Health Canada

35 page(s)
August 2023

Req # A-2022-001512

Adverse Drug Reactions (ADRs). Report numbers: 001025815, E2B_06026927.

Organization: Health Canada

17 page(s)
August 2023

Req # A-2023-000042

Adverse Drug Reactions (ADRs). Report numbers: 000913347, 000915274, 000918468, E2B_03533065, 000975599, E2B_04124641, E2B_04491922, 000969801, 000946974, 000933140.

Organization: Health Canada

145 page(s)
August 2023

Req # A-2023-000091

Adverse Drug Reactions (ADRs). Report numbers: 000944975, E2B_03832726, E2B_03862226, E2B_03864925, E2B_03900044, E2B_04033217, E2B_03950783, E2B_03950183, E2B_03936973, E2B_03901122.

Organization: Health Canada

306 page(s)
August 2023

Req # A-2023-000105

Adverse Drug Reactions (ADRs). Report numbers: E2B_04111518, E2B_05931170, E2B_05923911, E2B_05921979, E2B_05915556, E2B_05931183, E2B_05789236, E2B_05926116, E2B_02125118, E2B_05890650.

Organization: Health Canada

456 page(s)
August 2023

Req # A-2023-000146

Adverse Drug Reactions (ADRs). Report numbers: 000975181, 000975921, 000979128, 000975133, 000979719, 000980155, 000980158, E2B_04681040, E2B_04753160, E2B_04799563.

Organization: Health Canada

110 page(s)
August 2023

Req # A-2023-000165

Adverse Drug Reactions (ADRs) for VYVANSE. Report numbers: 001030861, E2B_06120444, E2B_06197294. ADRs for C1 ESTERASE INHIBITOR (HUMAN). Report numbers: E2B_06175782, E2B_06173304, E2B_06183872.

Organization: Health Canada

181 page(s)
August 2023

Req # A-2023-000188

Adverse Drug Reaction (ADR). Report number: 001029011.

Organization: Health Canada

24 page(s)
August 2023

Req # A-2023-000199

Adverse Drug Reactions (ADRs). Report numbers: E2B_05960758, E2B_06198551.

Organization: Health Canada

45 page(s)
August 2023

Req # A-2023-000206

Adverse Drug Reactions (ADRs). Report numbers: E2B_03239063, E2B_03448502, E2B_03500313, 000951098, E2B_03452251, E2B_04165811, 000962869, 000975222, 000976208, 000980710.

Organization: Health Canada

155 page(s)
August 2023
Date modified: